Literature DB >> 23988299

Differential expression and localization of saposin-like protein 2 of Fasciola hepatica.

Kimberly Cabán-Hernández1, Ana M Espino.   

Abstract

FhSAP2 is a novel antigen isolated from the adult fluke of Fasciola hepatica. Based on sequence similarity with amoebapores and other related proteins, it belongs to the saposin-like protein (SAPLIP) family. FhSAP2 has been shown to be highly immunogenic and capable of inducing protective immune responses in mice and rabbits challenged with F. hepatica. Moreover, FhSAP2 is also reactive with sera from humans with chronic fascioliasis. In the present study, we investigated the expression of FhSAP2 in various developmental stages of F. hepatica by qPCR and demonstrated that FhSAP2-mRNA species are up-regulated in undeveloped eggs, newly excysted juveniles, and adults, but down-regulated in the miracidium stage. Monoclonal antibodies against FhSAP2 were produced, and two clones that are positive to F. hepatica whole-body extract, but not reactive with extracts from other trematodes, were selected, expanded and used for histolocalization studies. Confocal immunofluorescence revealed the presence of native FhSAP2 in epithelial cells surrounding the gut, toward the outermost part of the tegument, and toward the tegumental cells of both adults and newly excysted juveniles. Published by Elsevier B.V.

Entities:  

Keywords:  Fasciola hepatica; Immunohistochemistry; Monoclonal antibody; qPCR

Mesh:

Substances:

Year:  2013        PMID: 23988299      PMCID: PMC3837425          DOI: 10.1016/j.actatropica.2013.08.012

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  42 in total

Review 1.  Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure.

Authors:  R S Munford; P O Sheppard; P J O'Hara
Journal:  J Lipid Res       Date:  1995-08       Impact factor: 5.922

Review 2.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

3.  Fasciola hepatica: development of monoclonal antibodies against somatic antigens and their characterization by ultrastructural localization of antibody binding.

Authors:  R E Hanna; A G Trudgett; A Anderson
Journal:  J Helminthol       Date:  1988-03       Impact factor: 2.170

4.  Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.

Authors:  M Leippe; J Andrä; R Nickel; E Tannich; H J Müller-Eberhard
Journal:  Mol Microbiol       Date:  1994-12       Impact factor: 3.501

5.  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.

Authors:  M Leippe; J Andrä; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases.

Authors:  M Córdova; L Reátegui; J R Espinoza
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jan-Feb       Impact factor: 2.184

7.  Kinetics of antibody-based antigen detection in serum and faeces of sheep experimentally infected with Fasciola hepatica.

Authors:  B E Duménigo; A M Espino; C M Finlay; M Mezo
Journal:  Vet Parasitol       Date:  2000-03-28       Impact factor: 2.738

8.  Dynamics of antigenemia and coproantigens during a human Fasciola hepatica outbreak.

Authors:  A M Espino; A Díaz; A Pérez; C M Finlay
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Cloning, characterization, and functional expression of cDNAs encoding glucose transporter proteins from the human parasite Schistosoma mansoni.

Authors:  P J Skelly; J W Kim; J Cunningham; C B Shoemaker
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

10.  Fasciola hepatica: development of monoclonal antibodies and their use to characterize a glycocalyx antigen in migrating flukes.

Authors:  R E Hanna; A G Trudgett
Journal:  Parasite Immunol       Date:  1983-07       Impact factor: 2.280

View more
  5 in total

1.  Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2.

Authors:  Marcos J Ramos-Benítez; Luis M Lopez-Cruz; Vasti Aguayo; Caleb Ruiz-Jimenez; Ana M Espino
Journal:  Mol Biol Rep       Date:  2018-07-21       Impact factor: 2.316

2.  Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.

Authors:  Francheska Rivera; Ana M Espino
Journal:  Exp Parasitol       Date:  2015-11-26       Impact factor: 2.011

3.  Across intra-mammalian stages of the liver f luke Fasciola hepatica: a proteomic study.

Authors:  Lucía Sánchez Di Maggio; Lucas Tirloni; Antonio F M Pinto; Jolene K Diedrich; John R Yates Iii; Uruguaysito Benavides; Carlos Carmona; Itabajara da Silva Vaz; Patricia Berasain
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

4.  Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model.

Authors:  Jose Rojas-Caraballo; Julio López-Abán; Darwin Andrés Moreno-Pérez; Belén Vicente; Pedro Fernández-Soto; Esther Del Olmo; Manuel Alfonso Patarroyo; Antonio Muro
Journal:  BMC Infect Dis       Date:  2017-01-23       Impact factor: 3.090

5.  Comparative genomics and transcriptomics of 4 Paragonimus species provide insights into lung fluke parasitism and pathogenesis.

Authors:  Bruce A Rosa; Young-Jun Choi; Samantha N McNulty; Hyeim Jung; John Martin; Takeshi Agatsuma; Hiromu Sugiyama; Thanh Hoa Le; Pham Ngoc Doanh; Wanchai Maleewong; David Blair; Paul J Brindley; Peter U Fischer; Makedonka Mitreva
Journal:  Gigascience       Date:  2020-07-01       Impact factor: 6.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.